Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00200525
Status:
COMPLETED
Last Update Posted:
2005-12-16
First Post:
2005-09-13
Brief Title:
Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease
Sponsor:
Mylan Bertek Pharmaceuticals
Organization:
Mylan Bertek Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2002-06
Completion Date Type:
None
First Submit Date:
2005-09-13
First Submit QC Date:
September 13 2005
Study First Post Date:
2005-09-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2005-12-15
Last Update Post Date:
2005-12-16
Last Update Post Date Type:
ESTIMATED